Relationship of Blood Metal Ion Levels and Leukocyte Profiles in Patients With Articular Surface Replacement Metal-on-Metal Hip Replacement

摘要

The purpose of this study was to compare blood leukocyte profiles and metal ion concentrations between hip resurfacing arthroplasty (articular surface replacement) patients with and without revision. A total of 25 articular surface replacement patients were recruited (10 with stable implants and 15 undergoing revision). Blood concentrations of chromium (Cr) and cobalt (Co) were measured. Flow cytometry was used to quantify the subpopulations of leukocytes, including CD14(+) monocytes, CD16(+) monocytes, CD3(+) T-lymphocytes, CD19(+) B-lymphocytes, CD4(+) helper T-cells, and CD45(+) RA memory vs naive T-cells. Patients undergoing revision had higher blood Co (mean, 10.85 mu g/L) and Cr (mean, 3.19 mu g/L) levels than patients with stable implants (mean Co, 3.06 mu g/L; mean Cr, 1.07 mu g/L) (P.05). The number of CD4(+) helper T-cells was higher in patients with stable implants (mean, 842 +/- 311 cells/mu L) than in patients undergoing revision (mean, 591 +/- 208 cells/mu L) (P.05). There was a significant association between total metal ion levels (Co+Cr) and the number of CD14(+) monocytes (P=.045) and inflammatory CD16(+) monocytes (P=.046). The authors observed that the increase in blood metal ions was associated with an increase in CD16(+) monocytes. They believe that continued analysis of blood leukocyte profiles may be helpful in defining differences among failed articular surface replacement, stable articular surface replacement, and failed metal-on-polyethylene implants.